| SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED Patent applications |
| Patent application number | Title | Published |
|---|
| 20120087959 | NANODISPERSION OF A DRUG AND PROCESS FOR ITS PREPARATION - The present invention provides a nanodispersion comprising nanoparticles having a mean size less than 300 nm dispersed in a vehicle comprising a water miscible solvent and water, said nanoparticles comprising one or more drugs, a polymer and a surfactant comprising a mixture of fatty acids or its salts and sterol or its derivatives or its salts. | 04-12-2012 |
| 20110275597 | PHARMACEUTICAL COMPOSITION - The present invention relates to a parenteral pharmaceutical composition comprising therapeutically effective amounts of N-(2-pyrazine)carbonyl-L-phenylalanine-L-leucine boronic acid or its salts or its derivatives and tromethamine wherein the composition is stable. | 11-10-2011 |
| 20110250271 | SPACED DRUG DELIVERY SYSTEM - The present invention provides to a method of administration of two or more therapeutically active agents comprising orally administering to a patient a spaced drug delivery system, wherein the time of release of the two or more therapeutically active agents is designed to provide desired control on the disease condition. The present invention also provides a method of administration of two or more therapeutically active agents comprising orally administering to a patient a spaced drug delivery system at a specified time prior to food intake by the patient. The present invention further provides a spaced drug delivery system that releases two or more antidiabetic agents at different times after oral administration, for the treatment of diabetes mellitus or conditions associated with diabetes mellitus. More particularly, the present invention provides a spaced drug delivery system that immediately releases one or more antidiabetic agents after oral administration of the system, and releases as a pulse one or more antidiabetic agents in a reliable manner at about a predetermined time after oral administration of the system. | 10-13-2011 |
| 20110166101 | MICROPARTICLES - A substantially porous, micro-particle comprising therapeutically effective amounts of tretinoin and ethyl cellulose | 07-07-2011 |
| 20110003816 | OPHTHALMIC COMPOSITION - An ophthalmic composition comprising therapeutically effective amount of a beta-blocker and a polymeric vehicle consisting essentially of a water soluble cellulose derivative and polyvinylpyrrolidone; wherein the composition is a clear aqueous solution with a viscosity id 20 cps to 60 cps. | 01-06-2011 |
| 20100297244 | NANODISPERSION - The present invention provides a nanodispersion comprising nanoparticles having a mean size less than 300 nm dispersed in a vehicle comprising a water miscible solvent and water, said nanoparticles comprising one or more taxane derivative, a polymer and a surfactant comprising a mixture of fatty acids or its salts and sterol or its derivatives or its salts. | 11-25-2010 |
| 20100163042 | INHALATION DEVICE - The present invention relates to an inhalation-activatable device for administration of medicament in powder form to the respiratory system of a patient. | 07-01-2010 |
| 20100137432 | OPHTHALMIC COMPOSITION COMPRISING A PROSTAGLANDIN - The present invention relates to a pharmaceutical composition suitable for ophthalmic use comprising one or more prostaglandin derivatives or salts, a stabilizing amount of polyethylene glycol hydroxystearate and pharmaceutically acceptable vehicle. | 06-03-2010 |
| 20100016814 | METERED DROP BOTTLE FOR DISPENSING MICROLITER AMOUNTS OF A LIQUID IN THE FORM OF A DROP - The present invention relates to a metered drop bottle for dispensing microliter amounts of a liquid in the form of a drop comprising: (a) a bottle with a flexible portion on the walls to decrease the internal volume by a fixed volume; (b) a plunger with a fixed stroke for depressing the flexible portion of the walls of the bottle; and (c) a nozzle tip having an internal and/or outer diameter no more than 1.2 mm. | 01-21-2010 |
| 20090208572 | ORAL CONTROLLED RELEASE TABLET - A method of reducing the risk of alcohol-induced dose-dumping of a therapeutically active ingredient comprising administering to human subjects who have ingested alcohol an oral controlled release tablet; said tablet comprising:
| 08-20-2009 |
| 20090110744 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS - A sustained release microsphere composition comprising—
| 04-30-2009 |
| 20080241238 | Controlled Release Coated Tablets Having Prolonged Gastric Retention - The present invention relates to a tablet composed of a core and a coating; said core is formed by two or more layers, wherein at least one of them contains an active agent ( | 10-02-2008 |
